149 related articles for article (PubMed ID: 17312667)
1. The nitric oxide pathway: is L-arginine a gate to the new millennium medicine? A meta-analysis of L-arginine effects.
Fisman EZ; Tenenbaum A; Shapira I; Pines A; Motro M
J Med; 1999; 30(3-4):131-48. PubMed ID: 17312667
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin-resistant JCR:LA-cp rat.
Proctor SD; Kelly SE; Vine DF; Russell JC
Metabolism; 2007 Oct; 56(10):1318-25. PubMed ID: 17884439
[TBL] [Abstract][Full Text] [Related]
3. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Böger RH
Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
[TBL] [Abstract][Full Text] [Related]
4. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
[TBL] [Abstract][Full Text] [Related]
5. L-Arginine: rediscovery in progress.
Tenenbaum A; Fisman EZ; Motro M
Cardiology; 1998 Dec; 90(3):153-9. PubMed ID: 9892762
[TBL] [Abstract][Full Text] [Related]
6. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM
Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and the endothelium: history and impact on cardiovascular disease.
Yetik-Anacak G; Catravas JD
Vascul Pharmacol; 2006 Nov; 45(5):268-76. PubMed ID: 17052961
[TBL] [Abstract][Full Text] [Related]
8. Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium.
San Martín R; Sobrevia L
Placenta; 2006 Jan; 27(1):1-10. PubMed ID: 16310032
[TBL] [Abstract][Full Text] [Related]
9. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
Lucotti P; Monti L; Setola E; La Canna G; Castiglioni A; Rossodivita A; Pala MG; Formica F; Paolini G; Catapano AL; Bosi E; Alfieri O; Piatti P
Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of nitric oxide synthesis by L-arginine supplementation in renal disease: is it good or bad?
De Nicola L; Minutolo R; Bellizzi V; Andreucci M; La Verde A; Cianciaruso B
Miner Electrolyte Metab; 1997; 23(3-6):144-50. PubMed ID: 9387105
[TBL] [Abstract][Full Text] [Related]
11. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
12. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test.
Jesse CR; Bortolatto CF; Savegnago L; Rocha JB; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1838-43. PubMed ID: 18773934
[TBL] [Abstract][Full Text] [Related]
13. [New possibilities in treatment of atherosclerosis--increase of nitric oxide synthesis by L-arginine supplementation].
Kielar M; Myrcha P; Pleban E
Pol Merkur Lekarski; 2004 Dec; 17(102):656-60. PubMed ID: 15771145
[TBL] [Abstract][Full Text] [Related]
14. Does L-arginine supplementation play a role in cerebral small vessels disease? Implication in the treatment of leukoaraiosis.
Calabrò RS; Gervasi G; Bramanti P
Med Hypotheses; 2011 Oct; 77(4):671-3. PubMed ID: 21803504
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide in flow-through venous flaps and effects of L-arginine and nitro-L-arginine methyl ester (L-NAME) on nitric oxide and flap survival in rabbits.
Ozyazgan I; Ozköse M; Başkol G
Ann Plast Surg; 2007 Nov; 59(5):550-7. PubMed ID: 17992151
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio.
Bode-Böger SM; Scalera F; Ignarro LJ
Pharmacol Ther; 2007 Jun; 114(3):295-306. PubMed ID: 17482266
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide pathway in hypertrophied heart: new therapeutic uses of nitric oxide donors.
Ruiz-Hurtado G; Delgado C
J Hypertens; 2010 Sep; 28 Suppl 1():S56-61. PubMed ID: 20823718
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and vascular insulin resistance.
Wu G; Meininger CJ
Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
[TBL] [Abstract][Full Text] [Related]
20. L-arginine transporters in cardiovascular disease: a novel therapeutic target.
Chin-Dusting JP; Willems L; Kaye DM
Pharmacol Ther; 2007 Dec; 116(3):428-36. PubMed ID: 17915331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
